对双相情感障碍和神经退行性疾病的前性研究
Xinming Xu1, Yaqi Li1, Hanyu Lu1
1Department of Nutrition and Food Hygiene, Ministry of Education Key Laboratory of Public Health Safety, School of Public Health, Institute of Nutrition, Fudan University, Shanghai, 200030, China.
NPJ Parkinson's disease
|October 3, 2024
概括
双极性障碍 (BD) 会增加痴呆症和帕金森病 (PD) 的风险. 治疗BD的药物可能会解释多达三分之二的这种关联,因此需要进一步调查潜在机制.
科学领域:
- 神经科学是一个神经科学.
- 精神病学是一个精神病学.
- 流行病学 流行病学
背景情况:
- 双极性障碍 (BD) 与神经退行性疾病 (如痴呆症和帕金森病 (PD)) 的更高风险有关.
- 在这种关联中,BD特异性药物的作用仍然不清楚.
- 了解这些联系对于患者护理和疾病预防至关重要.
研究的目的:
- 研究双相情绪障碍与发展痴呆症和帕金森病的风险之间的关联.
- 为了确定与BD相关的药物在多大程度上调解这些关联.
主要方法:
- 利用了来自501,233名在基线没有痴呆症或PD的参与者的英国生物库数据.
- 随访参与者的平均时间为13.8年,确定了痴呆症和PD的偶发病例.
- 在BD患者中使用生存分析来计算痴呆和PD的调整危险比率 (HR).
主要成果:
- 患有BD的参与者表现出明显增加的痴呆症 (aHR 2.52) 和PD (aHR 2.88) 的风险.
- 据估计,BD与神经退行性疾病之间的关联有三分之二可能是由用于治疗BD的药物介导的.
- 这表明药物对观察到的风险增加有很大影响.
结论:
- 双极性障碍是痴呆症和帕金森病的重要危险因素.
- BD药物似乎在这些神经退行性疾病的风险增加中发挥了相当大的作用.
- 进一步的研究是必不可少的,以阐明精确的机制,并确认这些发现.
相关概念视频
Bipolar Disorder
58
Bipolar disorder is a chronic mental health condition marked by significant mood fluctuations, including episodes of mania and depression. Elevated energy levels, heightened mood or irritability, impulsive behavior, reduced sleep needs, rapid speech, racing thoughts, inflated self-esteem, and distractibility characterize mania. Individuals with bipolar disorder often alternate between depressive and manic states, with periods of emotional stability lasting an average of six months to a year.
58
Alzheimer's Disease: Overview
451
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
451
Parkinson's Disease: Overview
492
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
492
Biological Causes of Schizophrenia
47
Schizophrenia, a severe psychiatric disorder, arises from a complex interplay of biological factors, including genetic predisposition, structural brain abnormalities, neurotransmitter dysregulation, and developmental irregularities. These factors collectively contribute to the onset and progression of the disorder, which typically manifests in late adolescence or early adulthood.
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin...
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin...
47
Neural Regulation
39.2K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.2K
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
507
Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
507


